Decreased dopamine activity predicts relapse in methamphetamine abusers

Molecular Psychiatry

Volumn 17, Issue 9, 2012, Pages 918-925

  Wang, G J ^a,b   Smith, L ^c   Volkow, N D ^d,e   Telang, F ^e   Logan, J ^a   Tomasi, D ^e   Wong, C T ^e   Hoffman, W ^f   Jayne, M ^e   Alia Klein, N ^a   Thanos, P ^e   Fowler, J S ^a,b  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^e NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^f PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

dopamine release; early withdrawal; methamphetamine; positron emission; relapse; tomography

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR; METHYLPHENIDATE; RACLOPRIDE C 11;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE ASSOCIATION; DOPAMINE RELEASE; FEMALE; FOLLOW UP; HUMAN; MALE; METHAMPHETAMINE DEPENDENCE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RELAPSE;

ADULT; AMPHETAMINE-RELATED DISORDERS; CARBON RADIOISOTOPES; CASE-CONTROL STUDIES; CORPUS STRIATUM; DOPAMINE; FEMALE; HUMANS; MALE; METHAMPHETAMINE; METHYLPHENIDATE; POSITRON-EMISSION TOMOGRAPHY; RACLOPRIDE; RECEPTORS, DOPAMINE D2; RECURRENCE; TIME FACTORS;

EID: 84866352511     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2011.86     Document Type: Article

References (39)

1. Seiden LS, Sabol KE. Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction. NIDA Res Monogr 1996; 163: 251-276.
2. Woolverton WL, Ricaurte GA, Forno LS, Seiden LS. Long-term effects of chronic methamphetamine administration in rhesus monkeys. Brain Res 1989; 486: 73-78. (Pubitemid 19102851)
3. Krasnova IN, Cadet JL. Methamphetamine toxicity and messengers of death. Brain Res Rev 2009; 60: 379-407.
4. Barr AM, Panenka WJ, MacEwan GW, Thornton AE, Lang DJ, Honer WG et al. The need for speed: an update on methamphetamine addiction. J Psychiatry Neurosci 2006; 31: 301-313. (Pubitemid 44497427)
5. Walsh SL, Wagner GC. Motor impairments after methamphetamine-induced neurotoxicity in the rat. J Pharmacol Exp Ther 1992; 263: 617-626.
6. Itoh J, Nabeshima T, Kameyama T. Utility of an elevated plus-maze for dissociation of amnesic and behavioral effects of drugs in mice. Eur J Pharmacol 1991; 194: 71-76.
7. Fantegrossi WE, Ciullo JR, Wakabayashi KT, De La Garza II R, Traynor JR, Woods JH. A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouse. Neuroscience 2008; 151: 533-543.
8. Thomas DM, Kuhn DM. Attenuated microglial activation mediates tolerance to the neurotoxic effects of methamphetamine. J Neurochem 2005; 92: 790-797. (Pubitemid 40229550)
9. McCann UD, Kuwabara H, Kumar A, Palermo M, Abbey R, Brasic J et al. Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users. Synapse 2008; 62: 91-100.
10. Lee B, London ED, Poldrack RA, Farahi J, Nacca A, Monterosso JR et al. Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity. J Neurosci 2009; 29: 14734-14740.
11. Cadet JL, Jayanthi S, Deng X. Methamphetamine-induced neuronal apoptosis involves the activation of multiple death pathways. Review. Neurotox Res 2005; 8: 199-206.
12. Seiden LS, Fischman MW, Schuster CR. Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys. Drug Alcohol Depend 1976; 1: 215-219.
13. Cass WA, Manning MW. Recovery of presynaptic dopaminergic functioning in rats treated with neurotoxic doses of methamphetamine. J Neurosci 1999; 19: 7653-7660. (Pubitemid 29404621)
14. Friedman SD, Castaneda E, Hodge GK. Long-term monoamine depletion, differential recovery, and subtle behavioral impairment following methamphetamine-induced neurotoxicity. Pharmacol Biochem Behav 1998; 61: 35-44. (Pubitemid 28477482)
15. Harvey DC, Lacan G, Tanious SP, Melega WP. Recovery from methamphetamine induced long-term nigrostriatal dopaminergic deficits without substantia nigra cell loss. Brain Res 2000; 871: 259-270. (Pubitemid 30433877)
16. Volkow ND, Chang L, Wang GJ, Fowler JS, Franceschi D, Sedler M et al. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci 2001; 21: 9414-9418. (Pubitemid 33096884)
17. Narendran R, Martinez D. Cocaine abuse and sensitization of striatal dopamine transmission: a critical review of the preclinical and clinical imaging literature. Synapse 2008; 62: 851-869.
18. Volkow ND, Wang GJ, Fowler JS, Thanos PP, Logan J, Gatley SJ et al. Brain DA D2 receptors predict reinforcing effects of stimulants in humans: replication study. Synapse 2002; 46: 79-82.
19. Volkow ND, Wang GJ, Newcorn J, Telang F, Solanto MV, Fowler JS et al. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 2007; 64: 932-940. (Pubitemid 47230617)
20. Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Jayne M et al. Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement. J Neurosci 2007; 27: 12700-12706. (Pubitemid 350127825)
21. Volkow ND, Wang GJ, Fowler JS, Tomasi D, Telang F. Quantification of behavior sackler colloquium: addiction: beyond dopamine reward circuitry. Proc Natl Acad Sci USA; published online 14 March 2011; e-pub ahead of print.
22. Volkow ND, Wang G, Fowler JS, Logan J, Gerasimov M, Maynard L et al. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci 2001; 21: RC121.
23. Logan J, Fowler JS, Volkow ND, Wolf AP, Dewey SL, Schlyer DJ et al. Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PETstudies in human subjects. J Cereb Blood Flow Metab 1990; 10: 740-747. (Pubitemid 20260955)
24. Lancaster JL, Tordesillas-Gutierrez D, Martinez M, Salinas F, Evans A, Zilles K et al. Bias between MNI and Talairach coordinates analyzed using the ICBM-152 brain template. Hum Brain Mapp 2007; 28: 1194-1205. (Pubitemid 350077483)
25. Lancaster JL, Woldorff MG, Parsons LM, Liotti M, Freitas CS, Rainey L et al. Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp 2000; 10: 120-131. (Pubitemid 30456920)
26. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002; 15: 273-289. (Pubitemid 34852226)
27. Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M et al. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 2001; 158: 2015-2021. (Pubitemid 33104107)
28. Xu W, Zhu JP, Angulo JA. Induction of striatal pre-and postsynaptic damage by methamphetamine requires the dopamine receptors. Synapse 2005; 58: 110-121. (Pubitemid 41443747)
29. Tong J, Ross BM, Schmunk GA, Peretti FJ, Kalasinsky KS, Furukawa Y et al. Decreased striatal dopamine D1 receptorstimulated adenylyl cyclase activity in human methamphetamine users. Am J Psychiatry 2003; 160: 896-903. (Pubitemid 41079574)
30. Volkow ND, Wang GJ, Fischman MW, Foltin R, Fowler JS, Franceschi D et al. Effects of route of administration on cocaine induced dopamine transporter blockade in the human brain. Life Sci 2000; 67: 1507-1515. (Pubitemid 30658707)
31. Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, Hitzemann R et al. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 1997; 386: 830-833. (Pubitemid 27181256)
32. Martinez D, Carpenter KM, Liu F, Slifstein M, Broft A, Friedman AC et al. Imaging dopamine transmission in cocaine dependence: link between neurochemistry and response to treatment. Am J Psychiatry 2011; 168: 634-641.
33. Martinez D, Narendran R, Foltin RW, Slifstein M, Hwang DR, Broft A et al. Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine. Am J Psychiatry 2007; 164: 622-629. (Pubitemid 46650194)
34. Robbins TW, Ersche KD, Everitt BJ. Drug addiction and the memory systems of the brain. Ann N YAcad Sci 2008; 1141: 1-21.
35. Yin HH, Ostlund SB, Knowlton BJ, Balleine BW. The role of the dorsomedial striatum in instrumental conditioning. Eur J Neurosci 2005; 22: 513-523. (Pubitemid 41097624)
36. Belin D, Everitt BJ. Cocaine seeking habits depend upon dopamine-dependent serial connectivity linking the ventral with the dorsal striatum. Neuron 2008; 57: 432-441. (Pubitemid 351179162)
37. Wong DF, Kuwabara H, Schretlen DJ, Bonson KR, Zhou Y, Nandi A et al. Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving. Neuropsychopharmacology 2006; 31: 2716-2727. (Pubitemid 44764168)
38. Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Childress AR et al. Dopamine increases in striatum do not elicit craving in cocaine abusers unless they are coupled with cocaine cues. Neuroimage 2008; 39: 1266-1273.
39. See RE, Elliott JC, Feltenstein MW. The role of dorsal vs ventral striatal pathways in cocaine-seeking behavior after prolonged abstinence in rats. Psychopharmacology (Berl) 2007; 194: 321-331. (Pubitemid 47389350)